发明授权
US08204729B2 Device for predicting and managing blood glucose by analyzing the effect of, and controlling, pharmacodynamic insulin equivalents 有权
通过分析药效学胰岛素当量的作用和控制来预测和控制血糖的装置

  • 专利标题: Device for predicting and managing blood glucose by analyzing the effect of, and controlling, pharmacodynamic insulin equivalents
  • 专利标题(中): 通过分析药效学胰岛素当量的作用和控制来预测和控制血糖的装置
  • 申请号: US12063665
    申请日: 2007-11-01
  • 公开(公告)号: US08204729B2
    公开(公告)日: 2012-06-19
  • 发明人: Philip Michael Sher
  • 申请人: Philip Michael Sher
  • 代理机构: Altimatia, LLC
  • 代理商 David M. Gange
  • 国际申请: PCT/US2007/083342 WO 20071101
  • 国际公布: WO2008/073609 WO 20080619
  • 主分类号: G06G7/58
  • IPC分类号: G06G7/58
Device for predicting and managing blood glucose by analyzing the effect of, and controlling, pharmacodynamic insulin equivalents
摘要:
Embodiments of the invention are devices for assisting users in the management of blood glucose concentration levels in patients. Devices of the invention provide users with detailed information related to the pharmacodynamic behavior of insulin in a patient. By displaying and accepting information concerning time-dependent rates and amounts of pharmacodynamic insulin unit equivalents, the devices of the invention empower the user to make effective decisions regarding insulin dosing.
信息查询
0/0